Researchers reported that structural variations in Acinetobacter capsules modulate both antibiotic resistance and host immune responses, shedding light on pathogenicity mechanisms of A. baumannii. The study links capsule composition to altered phagocytosis and drug susceptibility, offering potential targets for vaccine design or adjunctive therapies. Given A. baumannii’s role in hospital‑acquired, multidrug‑resistant infections, the findings could inform development of therapeutics that strip or neutralize capsule defenses to restore antibiotic activity and enhance immune clearance.